VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
FATE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
FATEFate Therapeutics, Inc.
$2.32$270M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFATEQuarterly Financials

Fate Therapeutics, Inc. (FATE) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Fate Therapeutics, Inc. (FATE) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

FATE Income Statement

Quarterly statement

FATE Income Statement

Fate Therapeutics, Inc. (FATE) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue2.08M1.3M1.37M1.74M1.91M1.63M1.86M3.07M6.77M1.93M1.68M1.94M933K58.98M44.36M14.98M18.55M18.41M17.07M14.22M
Revenue Growth %9.18%-20.26%-26.4%-43.36%-71.84%-15.38%10.98%58.13%625.83%-96.74%-96.22%-87.02%-94.97%220.3%159.86%5.31%38.3%65.27%7.38%88.21%
Cost of Goods Sold02.92M025.84M3.82M29.14M17.14M34.65M4.72M4.82M4.88M4.74M40.88M65.63M87.19M79.82M81.31M72.14M69.52M53.13M
COGS % of Revenue-224.63%-1484.09%200.37%1788.58%921.45%1127.2%69.71%250.44%291.47%243.83%4381.14%111.27%196.57%532.79%438.34%391.76%407.26%373.5%
Gross Profit2.08M-1.62M1.37M-24.1M-1.91M-27.51M-15.28M-31.58M2.05M-2.9M-3.21M-2.8M-39.94M-6.65M-42.84M-64.84M-62.76M-53.73M-52.45M-38.91M
Gross Margin %100%-124.63%100%-1384.09%-100.37%-1688.58%-821.45%-1027.2%30.29%-150.44%-191.47%-143.83%-4281.14%-11.27%-96.57%-432.79%-338.34%-291.76%-307.26%-273.5%
Gross Profit Growth %208.78%94.11%108.96%23.69%-193.32%-849.83%-376.13%-1029.33%105.13%56.44%92.51%95.69%36.35%87.62%18.33%-66.65%-81.32%-59.37%-127.18%-68.16%
Operating Expenses33.22M31.38M36.09M10.64M35.05M13.77M46.47M20.8M47.13M48.17M44.87M48.48M22.62M21.94M21.58M21.55M20.35M20.74M16.94M15.72M
OpEx % of Revenue1595.39%2415.78%2636.23%611.03%1838.18%845.49%2498.33%676.68%696.01%2502.44%2676.97%2493.98%2424.65%37.2%48.66%143.88%109.71%112.64%99.22%110.5%
Selling, General & Admin8.83M9.6M10.66M10.64M11.45M13.77M31.73M20.8M17.25M20.86M17.93M18.95M22.62M21.94M21.58M21.55M20.35M20.74M16.94M15.72M
SG&A % of Revenue424.06%738.72%779.04%611.03%600.16%845.49%1706.02%676.68%254.74%1083.38%1070.11%974.69%2424.65%37.2%48.66%143.88%109.71%112.64%99.22%110.5%
Research & Development24.39M21.79M25.43M25.84M27.43M29.14M33.61M34.65M34.6M32.14M31.82M34.27M40.88M65.63M87.19M79.82M81.31M72.14M69.52M53.13M
R&D % of Revenue1171.33%1677.06%1857.2%1484.09%1438.38%1788.58%1806.94%1127.2%510.99%1669.51%1898.33%1763.12%4381.14%111.27%196.57%532.79%438.34%391.76%407.26%373.5%
Other Operating Expenses000-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-31.13M-33M-34.72M-34.73M-36.97M-41.28M-61.75M-52.38M-45.08M-51.07M-48.08M-51.28M-62.56M-28.59M-64.42M-86.39M-83.11M-74.47M-69.38M-54.62M
Operating Margin %-1495.39%-2540.42%-2536.23%-1995.12%-1938.54%-2534.07%-3319.78%-1703.87%-665.73%-2652.88%-2868.44%-2637.81%-6705.79%-48.48%-145.23%-576.67%-448.05%-404.4%-406.48%-383.99%
Operating Income Growth %15.78%20.06%43.77%33.68%18%19.17%-28.44%-2.14%27.94%-78.61%25.37%40.64%24.72%61.6%7.15%-58.16%-77.66%-61.15%-107.74%-73.48%
EBITDA-30.55M-30.08M-31.66M-31.51M-33.69M-37.95M-56.94M-47.77M-40.36M-46.25M-43.19M-46.54M-58.1M-24.4M-59.58M-83.2M-80.15M-71.71M-67.18M-53.1M
EBITDA Margin %-1467.53%-2315.78%-2312.49%-1809.76%-1766.65%-2329.47%-3061.02%-1554%-596.01%-2402.44%-2576.97%-2393.98%-6227.12%-41.37%-134.32%-555.36%-432.08%-389.41%-393.56%-373.31%
EBITDA Growth %9.31%20.73%44.4%34.04%16.53%17.95%-31.82%-2.65%30.53%-89.53%27.51%44.06%27.51%65.97%11.31%-56.67%-75.71%-58.46%-106.45%-72.9%
D&A (Non-Cash Add-back)02.92M3.06M3.23M3.28M3.33M4.81M4.61M4.72M4.82M4.88M4.74M4.47M4.19M4.84M3.19M2.96M2.76M2.21M1.52M
EBIT-30.55M-31.21M-32.37M-32.25M-34.07M-37.62M-47.01M-47.68M-38.43M-48M-44.12M-51.28M-62.56M-28.59M-64.42M-86.39M-83.11M-74.47M-69.38M-54.62M
Net Interest Income1.55M1.87M2.22M2.58M2.92M3.34M3.87M4.44M4.83M4.15M4.41M4.7M4.38M3.69M2.88M1.79M757K418K297K289K
Interest Income1.55M1.87M2.22M2.58M2.92M3.34M3.87M4.44M4.83M4.15M4.41M4.7M4.38M3.69M2.88M1.79M757K418K297K289K
Interest Expense00000000000000000000
Other Income/Expense975K1.79M2.35M2.48M2.9M3.66M9.6M4.7M6.66M3.06M3.95M6.11M9.81M9.71M8.06M2.83M7M8.78M761K11.31M
Pretax Income-30.16M-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M
Pretax Margin %-1448.56%-2402.85%-2364.79%-1852.38%-1786.58%-2309.45%-2803.92%-1551.01%-567.44%-2493.71%-2632.58%-2323.56%-5654.34%-32.01%-127.07%-557.79%-410.29%-356.74%-402.02%-304.45%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-30.16M-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M
Net Margin %-1448.56%-2402.85%-2364.79%-1852.38%-1786.58%-2309.45%-2803.92%-1551.01%-567.44%-2493.71%-2632.58%-2323.56%-5654.34%-32.01%-127.07%-557.79%-410.29%-356.74%-402.02%-304.45%
Net Income Growth %11.48%17.03%37.92%32.36%11.34%21.63%-18.2%-5.55%27.16%-154.25%21.72%45.95%30.68%71.26%17.86%-92.95%-38.04%-45.69%-29.2%26.2%
Net Income (Continuing)-30.16M-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.25-0.26-0.27-0.27-0.29-0.32-0.44-0.40-0.33-0.47-0.45-0.46-0.54-0.09-0.50-0.83-0.79-0.59-0.72-0.45
EPS Growth %13.79%18.75%38.64%32.5%12.12%31.91%2.22%13.04%38.89%-402.67%10%44.58%31.65%84.15%30.56%-84.44%-36.21%-22.92%-18.03%33.82%
EPS (Basic)-0.25-0.26-0.27-0.27-0.29-0.32-0.44-0.40-0.33-0.47-0.45-0.46-0.54-0.09-0.50-0.83-0.79-0.59-0.72-0.45
Diluted Shares Outstanding120.4M120.03M118.79M119M118.53M118.38M117.79M117.77M117.47M101.1M98.61M98.57M98.4M98.05M97.22M97.02M96.7M96.34M95.79M95.41M
Basic Shares Outstanding120.4M120.03M118.79M119M118.53M118.38M117.79M117.77M117.47M101.1M98.61M98.57M98.4M98.05M97.22M97.02M96.7M96.34M95.79M95.41M
Dividend Payout Ratio--------------------